Skip to main content
. 2016 Dec 19;8(3):4289–4300. doi: 10.18632/oncotarget.14024

Figure 4. Validation of the LivFib Index for predicting liver fibrosis by the receiver-operating characteristic curve (ROC) in the total cohort and prospective cohort.

Figure 4

(A1, A2 and A3) The ROC of the LivFib Index for predicting significant fibrosis, advanced fibrosis and cirrhosis in the total cohort; (B1, B2 and B3) The ROC of the LivFib Index for predicting significant fibrosis, advanced fibrosis and cirrhosis in prospective cohort.